To view or add a comment, sign in Drug Safety Alert: Atorvastatin Recall (2025) The FDA has issued a Class II recall impacting 140,000+ bottles of atorvastatin (generic Lipitor) across 10mg, 20mg, 40mg, 80mg strengths due to failed dissolution testswhich can reduce effectiveness
The early data is encouraging
Mesodermal Migration: There are various theories to describe how a cleft occurs
Vendors who skip independent verification, or rely solely on manufacturer-provided COAs, can price lower because they have eliminated a significant expense
What is not receiving attention are clients who have tried every diet, trained extensively in camps, and end up exhausted from the level of commitment required to lose even small amounts of weight
Semaglutide GLP-1 injections do not provide immediate weight loss